Cargando…

Case report: Unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection

Concurrent hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is not uncommon as the two viruses shared the similar transmission routes. HCV is usually the dominant virus to suppress HBV, and HBV reactivation may occur during or after the course of anti-HCV treatment. By contrast, HCV rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yi-Tse, Chang, Ming-Ling, Liaw, Yun-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975149/ https://www.ncbi.nlm.nih.gov/pubmed/36873880 http://dx.doi.org/10.3389/fmed.2023.1136111

Ejemplares similares

Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
por: Su, Yi-Tse, et al.
Publicado: (2022)

Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
por: Pan, Jiali, et al.
Publicado: (2022)

Current Trend in Antiviral Therapy for Chronic Hepatitis B
por: Chien, Rong-Nan, et al.
Publicado: (2022)

Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up
por: Kaewdech, Apichat, et al.
Publicado: (2022)

Antiviral strategies for hepatitis E virus
por: Debing, Yannick, et al.
Publicado: (2014)

Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States
por: Argirion, Ilona, et al.
Publicado: (2023)

Challenges of Treating an Acute Hepatitis C Virus Infection With Concurrent Seizure Treatment in a Free Clinic
por: Blackmond, Nicholas, et al.
Publicado: (2022)

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
por: Chang, Ming-Ling, et al.
Publicado: (2022)

Coinfection of Hepatitis B and Hepatitis C Virus in Patients With Human Immunodeficiency Virus
por: Masroor, Hassan, et al.
Publicado: (2021)

Hepatitis B Virus Reactivation Associated With Therapeutic Interventions
por: Chang, Young, et al.
Publicado: (2022)

Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy
por: Cannon, Nathan A., et al.
Publicado: (2008)

Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy
por: Fusco, Dahlene N., et al.
Publicado: (2018)

Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2
por: Scalabrin, Simona, et al.
Publicado: (2022)

Hepatitis E Virus Superinfection: an Underrecognized Trigger of Acute Hepatitis B Virus Flare
por: Obeidat, Adham E, et al.
Publicado: (2021)

Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Patients Undergoing Maintenance Hemodialysis
por: Shabbir, Usama Bin, et al.
Publicado: (2022)

258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C
por: Millian, Daniel, et al.
Publicado: (2023)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Corrigendum: Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2
por: Scalabrin, Simona, et al.
Publicado: (2022)

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)

The urgency to expand the antiviral indications of general chronic hepatitis B patients
por: Fan, Ping, et al.
Publicado: (2023)

Concurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae
por: Marrie, Thomas J., et al.
Publicado: (2017)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
por: Liu, Jun-Ying, et al.
Publicado: (2012)

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment
por: Eltahla, Auda A., et al.
Publicado: (2017)

Sequence diversity of hepatitis D virus in Mongolia
por: Magvan, Battur, et al.
Publicado: (2023)

Biobanking for Viral Hepatitis Research
por: Ho, Erwin, et al.
Publicado: (2019)

Evolution of ferritin levels in hepatitis C patients treated with antivirals
por: Chang, Ming-Ling, et al.
Publicado: (2020)

Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease
por: Narladkar, Vinay, et al.
Publicado: (2023)

Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
por: Matsumoto, Yoshihiro, et al.
Publicado: (2013)

Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics
por: Tavis, John E, et al.
Publicado: (2011)

Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
por: Liang, Po-Cheng, et al.
Publicado: (2020)

Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure
por: Hartnell, Felicity, et al.
Publicado: (2020)

A241 CHARACTERIZING KUPFFER CELL-VIRUS INTERACTIONS IMMEDIATELY FOLLOWING VIRAL INVASION AND IN ACUTE HEPATITIS IN THE WOODCHUCK HEPATITIS VIRUS MODEL OF HEPATITIS B VIRUS INFECTIONS
por: Al-Yasiri, L, et al.
Publicado: (2023)

Innate Antiviral Immune Responses to Hepatitis B Virus
por: Ait-goughoulte, Malika, et al.
Publicado: (2010)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease
por: Tao, Xuemei, et al.
Publicado: (2022)

Hepatocyte Endoplasmic Reticulum Stress Inhibits Hepatitis B Virus Secretion and Delays Intracellular Hepatitis B Virus Clearance After Entecavir Treatment
por: Chen, Huan, et al.
Publicado: (2021)

Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
por: Li, Xiaofei, et al.
Publicado: (2021)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection
por: Joko, Kouji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pon8bpf9c5n598s4btf06p172t